Automatic classification of 123I-FP-CIT (DaTSCAN) SPECT images

Nuclear Medicine Communications

Volumn 32, Issue 8, 2011, Pages 699-707

  Towey, David J ^a   Bain, Peter G ^a   Nijran, Kuldip S ^a  

^a IMPERIAL COLLEGE HEALTHCARE NHS TRUST   (United Kingdom)

Author keywords

automatic classification; DaTSCAN; diagnostic accuracy; fluoropropyl carbomethoxy 3 4 iodophenyltropane; ioflupane; naive Bayes; principal component analysis; singular value decomposition

Indexed keywords

FLUOROPROPYLCARBOMETHOXY 3BETA 4 IODOPHENYLTROPANE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG; 2 CARBOMETHOXY 8 (3 FLUOROPROPYL) 3 (4 IODOPHENYL)TROPANE; 2-CARBOMETHOXY-8-(3-FLUOROPROPYL)-3-(4-IODOPHENYL)TROPANE; DIAGNOSTIC AGENT; TROPANE DERIVATIVE;

ARTICLE; DIAGNOSTIC ACCURACY; FOLLOW UP; GOVERNMENT; HUMAN; MAJOR CLINICAL STUDY; PARKINSONISM; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; AUTOMATION; COMPUTER ASSISTED DIAGNOSIS; FEMALE; MALE; METHODOLOGY; MIDDLE AGED; PRINCIPAL COMPONENT ANALYSIS; SCINTISCANNING;

AUTOMATION; FEMALE; HUMANS; IMAGE INTERPRETATION, COMPUTER-ASSISTED; MALE; MIDDLE AGED; PARKINSONIAN DISORDERS; PRINCIPAL COMPONENT ANALYSIS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TROPANES;

EID: 79960012613     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/MNM.0b013e328347cd09     Document Type: Article

References (28)

1. Booij J, Habraken JB, Bergmans P, Tissingh G,Winogrodzka A,Wolters EC, et al. Imaging of dopamine transporters with iodine-123-FP-CIT SPECT in healthy controls and patients with Parkinson's disease. J Nucl Med 1998; 39:1879-1884. (Pubitemid 28518886)
2. Booij J, Tissingh G, Boer GJ, Speelman JD, Stoof JC, Janssen AG, et al. [123I]FP-CIT SPECT shows a pronounced decline of striatal dopamine transporter labelling in early and advanced Parkinson's disease. J Neurol Neurosurg Psychiatry 1997; 62:133-140.
3. Booij J, Tissingh G, Winogrodzka A, Boer GJ, Stoof JC, Wolters EC, et al. Practical benefit of [123I]FP-CIT SPET in the demonstration of the dopaminergic deficit in Parkinson's disease. Eur J Nucl Med 1997; 24: 68-71. (Pubitemid 27122444)
4. Winogrodzka A, Bergmans P, Booij J, Van Royen EA, Janssen AG,Wolters EC. [123I]FP-CIT SPECT is a useful method to monitor the rate of dopaminergic degeneration in early-stage Parkinson's disease. J Neural Transm 2001; 108:1011-1019. (Pubitemid 32802097)
5. Tossici-Bolt L, Hoffmann SM, Kemp PM, Mehta RL, Fleming JS. Quantification of [(123)I]FP-CIT SPECT brain images: an accurate technique for measurement of the specific binding ratio. Eur J Nucl Med Mol Imaging 2006; 33:1491-1499. (Pubitemid 44885416)
6. Koch W, Radau PE, Hamann C, Tatsch K. Clinical testing of an optimized software solution for an automated, observer-independent evaluation of dopamine transporter SPECT studies. J Nucl Med 2005; 46: 1109-1118. (Pubitemid 43741072)
7. Koch W, Hamann C, Welsch J, Popperl G, Radau PE, Tatsch K. Is iterative reconstruction an alternative to filtered backprojection in routine processing of dopamine transporter SPECT studies? J Nucl Med 2005; 46: 1804-1811. (Pubitemid 46196641)
8. Morton RJ, Guy MJ, Clauss R, Hinton PJ, Marshall CA, Clarke EA. Comparison of different methods of DatSCAN quantification. Nucl Med Commun 2005; 26:1139-1146. (Pubitemid 41677606)
9. Staff RT, Ahearn TS,Wilson K, Counsell CE, Taylor K, Caslake R, et al. Shape analysis of 123I-N-omega-fluoropropyl-2-beta-carbomethoxy-3beta- (4-iodophenyl) nortropane single-photon emission computed tomography images in the assessment of patients with Parkinsonian syndromes. Nucl Med Commun 2009; 30:194-201.
10. Friston KJ. Statistical parametric mapping: the analysis of functional brain images. New York, NY, USA: Academic Press; 2006.
11. Colloby SJ, O'Brien JT, Fenwick JD, Firbank MJ, Burn DJ, McKeith IG, et al. The application of statistical parametric mapping to 123I-FP-CIT SPECT in dementia with Lewy bodies, Alzheimer's disease and Parkinson's disease. Neuroimage 2004; 23:956-966. (Pubitemid 39446529)
12. Barber DC. Digital computer processing of brain scans using principal components. Phys Med Biol 1976; 21:792-803.
13. Barber DC. The use of principal components in the quantitative analysis of gamma camera dynamic studies. Phys Med Biol 1980; 25:283-292. (Pubitemid 10169172)
14. Nijran KS. Analysis of dynamic radionuclide studies using principal components factor analysis. Dept Medical Physics And Clinical Engineering PhD, 1984.
15. Nijran KS, Barber DC. Towards automatic analysis of dynamic radionuclide studies using principal-components factor analysis. Phys Med Biol 1985; 30:1315-1325. (Pubitemid 16206453)
16. Houston AS, Kemp PM, Macleod MA. A method for assessing the significance of abnormalities in HMPO brain SPECT images. J Nucl Med 1994; 35:239-244. (Pubitemid 24048310)
17. Lozza C, Baron JC, Eidelberg D, Mentis MJ, Carbon M, Marie RM. Executive processes in Parkinson's disease: FDG-PET and network analysis. Hum Brain Mapp 2004; 22:236-245. (Pubitemid 38891002)
18. Hotelling H. Analysis of a complex of statistical variables into principal components. J Educ Psychol 1933; 24:417-441 and 498-520.
19. Pearson K. On lines and planes of closest fit to systems of points in space. Philosophical Magazine 1901; 2:559-572.
20. Towey DJ, Bain PG, Al-Nahhas A, Nijran KS. Data lead classification of 123I ioflupane images. Eur J Nucl Med Mol Imaging 2009; 36:OP189.
21. Lopez M, Ramirez J, Gorriz JM, Salas-Gonzalez D, Alvarez I, Segovia F, et al. Automatic tool for Alzheimer's disease diagnosis using PCA and Bayesian classification rules. Electronics Letters 2009; 45: 389-391.
22. Chang LT. A method for attenuation correction in radionuclide computed tomography. IEEE Trans Nuclear Science 1978; ns-25:638-643.
23. Towey DJ, Bain PG, Al-Nahhas A, Nijran KS. Optimizing iterative reconstruction technique for 123-I ioflupane (DaTSCAN) imaging. Annual Congress of the European Association of Nuclear Medicine 2008; 35: S336.
24. Rasband WS. Image J. Bethesda, Maryland, USA: US National Institutes of Health, 1997.
25. Rorden C, Brett M. Stereotaxic display of brain lesions. Behav Neurol 2000; 12:191-200. (Pubitemid 32843166)
26. Pereira F, Mitchell T, Botvinick M. Machine learning classifiers and fMRI: a tutorial overview. Neuroimage 2009; 45:S199-S209.
27. Lopez M, Ramirez J, Gorriz JM, Alvarez I, Salas-Gonzalez D, Segovia F, et al. SVM-based CAD system for early detection of the Alzheimer's disease using kernel PCA and LDA. Neurosci Lett 2009; 464:233-238.
28. Pedro D, Michael JP. On the optimality of the simple Bayesian classifier under zero-one loss. Machine Learning 1997; 29:103-130.